Skip to Main Content

Author Details

Theodore L DeWeese
Johns Hopkins University School of Medicine
1991
219
55
PMIDPaper TitleJournal TitlePublished Year
37812042TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment.Prostate2024
37558543Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer.Eur Urol Oncol2024
36316967The impact of salvage radiotherapy initiation at PSA⿿⿤⿿0.5⿿ng/ml on metastasis-free survival in patients with relapsed prostate cancer following prostatectomy.Prostate2023
37905029Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer.bioRxiv2023
37173210Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer.Eur Urol2023
36736631Radiotherapy Deserts: The Impact of Race, Poverty, and the Rural-Urban Continuum on Density of Providers and the Use of Radiation Therapy in the US.Int J Radiat Oncol Biol Phys2023
36708787WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer.Int J Radiat Oncol Biol Phys2023
36179990External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis.Int J Radiat Oncol Biol Phys2023
36373171Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate.Prostate2023
36367998Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.J Clin Oncol2023
34670241Establishing a Deaf and American Sign Language Inclusive Residency Program.Acad Med2022
36001857Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.J Clin Oncol2022
36306499Evaluation of the Clinical Utility of the Bone Metastases Ensemble Trees for Survival Decision Support Platform (BMETS-DSP): A Case-Based Pilot Assessment.JCO Clin Cancer Inform2022
34861998Mechanisms, Challenges, and Opportunities in Combined Radiation and Hormonal Therapies.Semin Radiat Oncol2022
35014708Radiating the prostate bed in relapsed oligometastatic prostate cancer: How comprehensive should we be?Prostate2022
35013522Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.Prostate Cancer Prostatic Dis2022
35090073Improving providers' survival estimates and selection of prognosis- and guidelines-appropriate treatment for patients with symptomatic bone metastases: Development of the Bone Metastases Ensemble Trees for Survival Decision Support Platform.J Eval Clin Pract2022
35107973Correction to "Suppression of DNA Polymerase β Activity is Synthetically Lethal in BRCA1-Deficient Cells".ACS Chem Biol2022
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
30836168Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.Int J Radiat Oncol Biol Phys2021
33760638External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone Metastases.JCO Clin Cancer Inform2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
34793736The Model of an ASTRO Servant Leader.Int J Radiat Oncol Biol Phys2021
33989583In Reply to Nieder.Int J Radiat Oncol Biol Phys2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34240844Suppression of DNA Polymerase β Activity Is Synthetically Lethal in BRCA1-Deficient Cells.ACS Chem Biol2021
34032307Longitudinal measurement of subcutaneous and intratibial human prostate cancer xenograft growth and response to ionizing radiation by plasma Alu and LINE-1 ctDNA: A comparison to standard methods.Prostate2021
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
33451978Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer.Clin Cancer Res2021
33270093Drug-Radiotherapy Combinations in 2020-A Landmark Year?JAMA Oncol2021
32798608Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer.Int J Radiat Oncol Biol Phys2021
32536574Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer.Eur Urol Oncol2021
30992160Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.Eur Urol2020
31647971Examinations in Radiation Oncology: Listening, Learning, and Looking Forward Together.Int J Radiat Oncol Biol Phys2020
31812829Improvements in Physician Clinical Workflow Measures After Implementation of a Dashboard Program.Pract Radiat Oncol2020
31805367Frequency of Complicated Symptomatic Bone Metastasis Over a Breadth of Operational Definitions.Int J Radiat Oncol Biol Phys2020
31918595Design and construction of a Maxwell-type induction coil for magnetic nanoparticle hyperthermia.Int J Hyperthermia2020
31978591Who Benefits From a Prostate Rectal Spacer? Secondary Analysis of a Phase III Trial.Pract Radiat Oncol2020
33258482Impact of radiation dose on recurrence in high-risk prostate cancer patients.Prostate2020
33090219Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.JAMA Oncol2020
33083639Confronting Racism in Radiation Oncology: Now Is the Time and Today Is the Day.Adv Radiat Oncol2020
33427664Initial Impact and Operational Response of Radiation Oncology Practices to the COVID-19 Pandemic in the United States, Europe, and Latin America.Int J Radiat Oncol Biol Phys2020
33426990Magnetic nanoparticle hyperthermia for treating locally advanced unresectable and borderline resectable pancreatic cancers: the role of tumor size and eddy-current heating.Int J Hyperthermia2020
32890535Is This Au Revoir or a Permanent Farewell to In-Person Meetings?Int J Radiat Oncol Biol Phys2020
32890512Initial Impact and Operational Responses to the COVID-19 Pandemic by American Radiation Oncology Practices.Int J Radiat Oncol Biol Phys2020
32446952Developing an Improved Statistical Approach for Survival Estimation in Bone Metastases Management: The Bone Metastases Ensemble Trees for Survival (BMETS) Model.Int J Radiat Oncol Biol Phys2020
32215577Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.JAMA Oncol2020
32487038A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS).BMC Cancer2020
31454660Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.Urology2020
30562547Needs and Challenges for Radiation Oncology in the Era of Precision Medicine.Int J Radiat Oncol Biol Phys2019
  • 1 - 50 of 219

Recommended Authors

Niluja Thiruthaneeswaran
The University of Sydney, Westmead Hospital
Career Start Year 2014
Number of shared co-authors 5
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 22
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 21
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 6
John Thoms
Memorial University
Career Start Year 2008
Number of shared co-authors 4
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 7
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 10
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 29
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 6
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Career Start Year 2004
Number of shared co-authors 20
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 6
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 4
Austin N Kirschner
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 1
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 15
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 37
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 49
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 10
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 14
Simeng Suy
MedStar Georgetown University Hospital
Career Start Year 1996
Number of shared co-authors 30
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 4
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 28
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 6
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 6
William Robert Lee
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 43
Robert G Bristow
University of Toronto
Career Start Year 1989
Number of shared co-authors 32
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 48
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 26
Mack Roach
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 70
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 13
Andre Konski
Chester County Hospital
Career Start Year 1982
Number of shared co-authors 8

Collaborators

Danny Y Song
Johns Hopkins University School of Medicine
Co-authored papers 59
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 43
Todd McNutt
Johns Hopkins University School of Medicine
Co-authored papers 33
Curtiland Deville
Johns Hopkins University
Co-authored papers 29
Stephen Greco
Johns Hopkins University School of Medicine
Co-authored papers 25
Michael A Carducci
Johns Hopkins School of Medicine
Co-authored papers 23
Mario A Eisenberger
Johns Hopkins University
Co-authored papers 18
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 16
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Co-authored papers 16
Ashley E Ross
Northwestern University
Co-authored papers 14
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 13
Ryan Phillips
Johns Hopkins University
Co-authored papers 11
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 11
Wolfgang Lilleby
Oslo University Hospital
Co-authored papers 10
Channing J Paller
Johns Hopkins University School of Medicine
Co-authored papers 10
Eric M Horwitz
Fox Chase Cancer Center
Co-authored papers 9
Thomas M Pisansky
Mayo Clinic
Co-authored papers 9
Michael L Steinberg
University of California los angeles
Co-authored papers 9
Amar U Kishan
University of California los angeles
Co-authored papers 9
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 9
Jay P Ciezki
Cleveland Clinic
Co-authored papers 8
Richard G Stock
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 8
Eyad Abu-Isa
Ascension Providence Hospital
Co-authored papers 8
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 8
David Jeffrey Demanes
University of California los angeles
Co-authored papers 8
Trude B Wedde
Oslo University Hospital
Co-authored papers 8
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 8
Chandana A Reddy
Cleveland Clinic
Co-authored papers 8
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 8
Release 1.2